These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28287686)

  • 1. Cyproheptadine: A Potentially Effective Treatment for Functional Gastrointestinal Disorders in Children.
    Krasaelap A; Madani S
    Pediatr Ann; 2017 Mar; 46(3):e120-e125. PubMed ID: 28287686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyproheptadine Use in Children With Functional Gastrointestinal Disorders.
    Madani S; Cortes O; Thomas R
    J Pediatr Gastroenterol Nutr; 2016 Mar; 62(3):409-13. PubMed ID: 26308312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interventions on early functional gastrointestinal disorders.
    Salvatore S; Barberi S; Borrelli O; Castellazzi A; Di Mauro D; Di Mauro G; Doria M; Francavilla R; Landi M; Martelli A; Miniello VL; Simeone G; Verduci E; Verga C; Zanetti MA; Staiano A;
    Ital J Pediatr; 2016 Jul; 42(1):68. PubMed ID: 27423188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal Pharmacology.
    Saps M; Miranda A
    Handb Exp Pharmacol; 2017; 239():147-176. PubMed ID: 28236087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders.
    Martinucci I; Blandizzi C; de Bortoli N; Bellini M; Antonioli L; Tuccori M; Fornai M; Marchi S; Colucci R
    Pharmacogenomics; 2015; 16(5):523-39. PubMed ID: 25916523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological concepts of functional dyspepsia and irritable bowel syndrome future pharmacotherapy.
    Dobrek Ł; Thor PJ
    Acta Pol Pharm; 2009; 66(5):447-60. PubMed ID: 19894640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment of abdominal pain related functional gastrointestinal disorders.
    Bonilla S; Saps M
    J Pediatr Gastroenterol Nutr; 2011 Dec; 53 Suppl 2():S38-40. PubMed ID: 22235469
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical utility of Rome criteria managing functional gastrointestinal disorders in pediatric primary care.
    Primavera G; Amoroso B; Barresi A; Belvedere L; D'Andrea C; Ferrara D; Cascio AL; Rizzari S; Sanfilippo E; Spataro A; Zangara D; Magazzù G
    Pediatrics; 2010 Jan; 125(1):e155-61. PubMed ID: 20008416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Pain-Predominant Functional Gastrointestinal Disorders in the Adolescent.
    Rosen JM; Alioto A; Saps M
    Adolesc Med State Art Rev; 2016; 27(1):34-56. PubMed ID: 27363232
    [No Abstract]   [Full Text] [Related]  

  • 10. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.
    Manabe N; Wong BS; Camilleri M
    Expert Opin Investig Drugs; 2010 Jun; 19(6):765-75. PubMed ID: 20408739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyproheptadine for the treatment of functional abdominal pain in childhood: a double-blinded randomized placebo-controlled trial.
    Sadeghian M; Farahmand F; Fallahi GH; Abbasi A
    Minerva Pediatr; 2008 Dec; 60(6):1367-74. PubMed ID: 18971897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of oral erythromycin for the treatment of gastrointestinal dysmotility in preterm infants.
    Ng PC
    Neonatology; 2009; 95(2):97-104. PubMed ID: 19218823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New pharmacologic therapies in gastrointestinal disease.
    Wallace JL; Ferraz JG
    Gastroenterol Clin North Am; 2010 Sep; 39(3):709-20. PubMed ID: 20951926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prokinetic agents (prokinetics) in the treatment of motor disorders of the gastrointestinal tract].
    Frol'kis AV
    Ter Arkh; 1998; 70(2):69-72. PubMed ID: 9551580
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pediatric functional gastrointestinal disorders: a questionnaire on pediatric gastrointestinal symptoms based on Rome III criteria].
    Buonavolontà R; Boccia G; Turco R; Quitadamo P; Russo D; Staiano A
    Minerva Pediatr; 2009 Feb; 61(1):67-91. PubMed ID: 19180003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of functional bowel disorders: any light at the end of the tunnel?
    Boeckxstaens GE
    Curr Opin Pharmacol; 2008 Dec; 8(6):669-70. PubMed ID: 18835367
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyproheptadine is an effective appetite stimulant in cystic fibrosis.
    Homnick DN; Homnick BD; Reeves AJ; Marks JH; Pimentel RS; Bonnema SK
    Pediatr Pulmonol; 2004 Aug; 38(2):129-34. PubMed ID: 15211696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.
    Camilleri M
    Clin Pharmacol Ther; 2012 Jan; 91(1):44-59. PubMed ID: 22071696
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional gastrointestinal disorders in migrainous children: efficacy of flunarizine.
    Boccia G; Del Giudice E; Crisanti AF; Strisciuglio C; Romano A; Staiano A
    Cephalalgia; 2006 Oct; 26(10):1214-9. PubMed ID: 16961789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid therapy for gastrointestinal diseases.
    Triadafilopoulos G
    Expert Opin Drug Saf; 2014 May; 13(5):563-72. PubMed ID: 24742121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.